APO Research

APO RESEARCH · REPORT

Venous Thromboembolism (VTE) Prevention Software

Selected research

Industry Growth & Trends

Global Venous Thromboembolism (VTE) Prevention Software Industry Growth and Trends Forecast to 2032

Market perspective

According to APO Research, the global Venous Thromboembolism (VTE) Prevention Software market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Venous Thromboembolism (VTE) Prevention Software is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Venous Thromboembolism (VTE) Prevention Software is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Venous Thromboembolism (VTE) Prevention Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Venous Thromboembolism (VTE) Prevention Software market include Aidoc, Xiangyu Medical, Xunfei Healthcare, Shanghai SYNYI AI, Shanghai Clinbrain, SmartCode Technology, Zhixuan Internet, Biovision Software and Lianyungang Xunda Seal Engraving Service, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Venous Thromboembolism (VTE) Prevention Software market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Venous Thromboembolism (VTE) Prevention Software market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Venous Thromboembolism (VTE) Prevention Software market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Venous Thromboembolism (VTE) Prevention Software.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Venous Thromboembolism (VTE) Prevention Software market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Venous Thromboembolism (VTE) Prevention Software Market by Company

Aidoc

Xiangyu Medical

Xunfei Healthcare

Shanghai SYNYI AI

Shanghai Clinbrain

SmartCode Technology

Zhixuan Internet

Biovision Software

Lianyungang Xunda Seal Engraving Service

Donghua Medical Technology

Guangzhou Laino Information Technology

Venous Thromboembolism (VTE) Prevention Software Segment by Type

Cloud-based

On-premise

Venous Thromboembolism (VTE) Prevention Software Segment by Application

Hospital

Clinic

Other

Venous Thromboembolism (VTE) Prevention Software Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Venous Thromboembolism (VTE) Prevention Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Venous Thromboembolism (VTE) Prevention Software and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Venous Thromboembolism (VTE) Prevention Software.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Venous Thromboembolism (VTE) Prevention Software companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Venous Thromboembolism (VTE) Prevention Software Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Venous Thromboembolism (VTE) Prevention Software Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Venous Thromboembolism (VTE) Prevention Software Market Share by Region (2021-2026) Table 4. Global Venous Thromboembolism (VTE) Prevention Software Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Venous Thromboembolism (VTE) Prevention Software Market Share by Region (2027-2032) Table 6. Global Venous Thromboembolism (VTE) Prevention Software Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Venous Thromboembolism (VTE) Prevention Software Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Venous Thromboembolism (VTE) Prevention Software Market Size Share by Type (2021-2026) Table 9. Global Venous Thromboembolism (VTE) Prevention Software Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Venous Thromboembolism (VTE) Prevention Software Market Size Share Forecasted by Type (2027-2032) Table 11. North America Venous Thromboembolism (VTE) Prevention Software Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Venous Thromboembolism (VTE) Prevention Software Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Venous Thromboembolism (VTE) Prevention Software Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Venous Thromboembolism (VTE) Prevention Software Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Venous Thromboembolism (VTE) Prevention Software Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Venous Thromboembolism (VTE) Prevention Software Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Venous Thromboembolism (VTE) Prevention Software Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Venous Thromboembolism (VTE) Prevention Software Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Venous Thromboembolism (VTE) Prevention Software Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Venous Thromboembolism (VTE) Prevention Software Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Venous Thromboembolism (VTE) Prevention Software Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Venous Thromboembolism (VTE) Prevention Software Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Venous Thromboembolism (VTE) Prevention Software Market Size Share by Application (2021-2026) Table 24. Global Venous Thromboembolism (VTE) Prevention Software Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Venous Thromboembolism (VTE) Prevention Software Market Size Share Forecasted by Application (2027-2032) Table 26. North America Venous Thromboembolism (VTE) Prevention Software Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Venous Thromboembolism (VTE) Prevention Software Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Venous Thromboembolism (VTE) Prevention Software Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Venous Thromboembolism (VTE) Prevention Software Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Venous Thromboembolism (VTE) Prevention Software Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Venous Thromboembolism (VTE) Prevention Software Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Venous Thromboembolism (VTE) Prevention Software Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Venous Thromboembolism (VTE) Prevention Software Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Venous Thromboembolism (VTE) Prevention Software Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Venous Thromboembolism (VTE) Prevention Software Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Venous Thromboembolism (VTE) Prevention Software Industry Trends Table 37. Venous Thromboembolism (VTE) Prevention Software Industry Drivers Table 38. Venous Thromboembolism (VTE) Prevention Software Industry Opportunities and Challenges Table 39. Venous Thromboembolism (VTE) Prevention Software Industry Restraints Table 40. Global Venous Thromboembolism (VTE) Prevention Software Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Venous Thromboembolism (VTE) Prevention Software Revenue Market Share by Company (2021-2026) Table 42. Global Venous Thromboembolism (VTE) Prevention Software Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Venous Thromboembolism (VTE) Prevention Software Key Company Headquarters & Area Served Table 44. Global Venous Thromboembolism (VTE) Prevention Software Company, Product Type & Application Table 45. Global Venous Thromboembolism (VTE) Prevention Software Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Venous Thromboembolism (VTE) Prevention Software by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Aidoc Company Information Table 49. Aidoc Business Overview Table 50. Aidoc Venous Thromboembolism (VTE) Prevention Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Aidoc Venous Thromboembolism (VTE) Prevention Software Product Portfolio Table 52. Aidoc Recent Development Table 53. Xiangyu Medical Company Information Table 54. Xiangyu Medical Business Overview Table 55. Xiangyu Medical Venous Thromboembolism (VTE) Prevention Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Xiangyu Medical Venous Thromboembolism (VTE) Prevention Software Product Portfolio Table 57. Xiangyu Medical Recent Development Table 58. Xunfei Healthcare Company Information Table 59. Xunfei Healthcare Business Overview Table 60. Xunfei Healthcare Venous Thromboembolism (VTE) Prevention Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Xunfei Healthcare Venous Thromboembolism (VTE) Prevention Software Product Portfolio Table 62. Xunfei Healthcare Recent Development Table 63. Shanghai SYNYI AI Company Information Table 64. Shanghai SYNYI AI Business Overview Table 65. Shanghai SYNYI AI Venous Thromboembolism (VTE) Prevention Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Shanghai SYNYI AI Venous Thromboembolism (VTE) Prevention Software Product Portfolio Table 67. Shanghai SYNYI AI Recent Development Table 68. Shanghai Clinbrain Company Information Table 69. Shanghai Clinbrain Business Overview Table 70. Shanghai Clinbrain Venous Thromboembolism (VTE) Prevention Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Shanghai Clinbrain Venous Thromboembolism (VTE) Prevention Software Product Portfolio Table 72. Shanghai Clinbrain Recent Development Table 73. SmartCode Technology Company Information Table 74. SmartCode Technology Business Overview Table 75. SmartCode Technology Venous Thromboembolism (VTE) Prevention Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. SmartCode Technology Venous Thromboembolism (VTE) Prevention Software Product Portfolio Table 77. SmartCode Technology Recent Development Table 78. Zhixuan Internet Company Information Table 79. Zhixuan Internet Business Overview Table 80. Zhixuan Internet Venous Thromboembolism (VTE) Prevention Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Zhixuan Internet Venous Thromboembolism (VTE) Prevention Software Product Portfolio Table 82. Zhixuan Internet Recent Development Table 83. Biovision Software Company Information Table 84. Biovision Software Business Overview Table 85. Biovision Software Venous Thromboembolism (VTE) Prevention Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Biovision Software Venous Thromboembolism (VTE) Prevention Software Product Portfolio Table 87. Biovision Software Recent Development Table 88. Lianyungang Xunda Seal Engraving Service Company Information Table 89. Lianyungang Xunda Seal Engraving Service Business Overview Table 90. Lianyungang Xunda Seal Engraving Service Venous Thromboembolism (VTE) Prevention Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Lianyungang Xunda Seal Engraving Service Venous Thromboembolism (VTE) Prevention Software Product Portfolio Table 92. Lianyungang Xunda Seal Engraving Service Recent Development Table 93. Donghua Medical Technology Company Information Table 94. Donghua Medical Technology Business Overview Table 95. Donghua Medical Technology Venous Thromboembolism (VTE) Prevention Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Donghua Medical Technology Venous Thromboembolism (VTE) Prevention Software Product Portfolio Table 97. Donghua Medical Technology Recent Development Table 98. Guangzhou Laino Information Technology Company Information Table 99. Guangzhou Laino Information Technology Business Overview Table 100. Guangzhou Laino Information Technology Venous Thromboembolism (VTE) Prevention Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Guangzhou Laino Information Technology Venous Thromboembolism (VTE) Prevention Software Product Portfolio Table 102. Guangzhou Laino Information Technology Recent Development Table 103. North America Venous Thromboembolism (VTE) Prevention Software Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 104. North America Venous Thromboembolism (VTE) Prevention Software Market Size by Country (2021-2026) & (US$ Million) Table 105. North America Venous Thromboembolism (VTE) Prevention Software Market Share by Country (2021-2026) Table 106. North America Venous Thromboembolism (VTE) Prevention Software Market Size Forecast by Country (2027-2032) & (US$ Million) Table 107. North America Venous Thromboembolism (VTE) Prevention Software Market Share Forecast by Country (2027-2032) Table 108. Europe Venous Thromboembolism (VTE) Prevention Software Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 109. Europe Venous Thromboembolism (VTE) Prevention Software Market Size by Country (2021-2026) & (US$ Million) Table 110. Europe Venous Thromboembolism (VTE) Prevention Software Market Share by Country (2021-2026) Table 111. Europe Venous Thromboembolism (VTE) Prevention Software Market Size Forecast by Country (2027-2032) & (US$ Million) Table 112. Europe Venous Thromboembolism (VTE) Prevention Software Market Share Forecast by Country (2027-2032) Table 113. Asia-Pacific Venous Thromboembolism (VTE) Prevention Software Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 114. Asia-Pacific Venous Thromboembolism (VTE) Prevention Software Market Size by Country (2021-2026) & (US$ Million) Table 115. Asia-Pacific Venous Thromboembolism (VTE) Prevention Software Market Share by Country (2021-2026) Table 116. Asia-Pacific Venous Thromboembolism (VTE) Prevention Software Market Size Forecast by Country (2027-2032) & (US$ Million) Table 117. Asia-Pacific Venous Thromboembolism (VTE) Prevention Software Market Share Forecast by Country (2027-2032) Table 118. Latin America Venous Thromboembolism (VTE) Prevention Software Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 119. Latin America Venous Thromboembolism (VTE) Prevention Software Market Size by Country (2021-2026) & (US$ Million) Table 120. Latin America Venous Thromboembolism (VTE) Prevention Software Market Share by Country (2021-2026) Table 121. Latin America Venous Thromboembolism (VTE) Prevention Software Market Size Forecast by Country (2027-2032) & (US$ Million) Table 122. Latin America Venous Thromboembolism (VTE) Prevention Software Market Share Forecast by Country (2027-2032) Table 123. Middle East & Africa Venous Thromboembolism (VTE) Prevention Software Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 124. Middle East & Africa Venous Thromboembolism (VTE) Prevention Software Market Size by Country (2021-2026) & (US$ Million) Table 125. Middle East & Africa Venous Thromboembolism (VTE) Prevention Software Market Share by Country (2021-2026) Table 126. Middle East & Africa Venous Thromboembolism (VTE) Prevention Software Market Size Forecast by Country (2027-2032) & (US$ Million) Table 127. Middle East & Africa Venous Thromboembolism (VTE) Prevention Software Market Share Forecast by Country (2027-2032) Table 128. Research Programs/Design for This Report Table 129. Authors List of This Report Table 130. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Venous Thromboembolism (VTE) Prevention Software Product Image Figure 3. Global Venous Thromboembolism (VTE) Prevention Software Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Venous Thromboembolism (VTE) Prevention Software Market Size (2021-2032) & (US$ Million) Figure 5. Global Venous Thromboembolism (VTE) Prevention Software Market Share by Region: 2025 VS 2032 Figure 6. Global Venous Thromboembolism (VTE) Prevention Software Market Share by Region (2021-2032) Figure 7. North America Venous Thromboembolism (VTE) Prevention Software Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Venous Thromboembolism (VTE) Prevention Software Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Venous Thromboembolism (VTE) Prevention Software Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Venous Thromboembolism (VTE) Prevention Software Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Venous Thromboembolism (VTE) Prevention Software Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Cloud-based Image Figure 13. Global Cloud-based Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. On-premise Image Figure 15. Global On-premise Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Global Venous Thromboembolism (VTE) Prevention Software Market Size Overview by Type (2021-2032) & (US$ Million) Figure 17. Global Venous Thromboembolism (VTE) Prevention Software Market Share by Type 2025 VS 2032 Figure 18. North America Venous Thromboembolism (VTE) Prevention Software Market Size Share by Type (2021-2032) Figure 19. Europe Venous Thromboembolism (VTE) Prevention Software Market Size Share by Type (2021-2032) Figure 20. Asia-Pacific Venous Thromboembolism (VTE) Prevention Software Market Size Share by Type (2021-2032) Figure 21. Latin America Venous Thromboembolism (VTE) Prevention Software Market Size Share by Type (2021-2032) Figure 22. Middle East and Africa Venous Thromboembolism (VTE) Prevention Software Market Size Share by Type (2021-2032) Figure 23. Hospital Image Figure 24. Global Hospital Market Size YoY Growth (2021-2032) & (US$ Million) Figure 25. Clinic Image Figure 26. Global Clinic Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Other Image Figure 28. Global Other Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Global Venous Thromboembolism (VTE) Prevention Software Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Venous Thromboembolism (VTE) Prevention Software Market Share by Application 2025 VS 2032 Figure 31. North America Venous Thromboembolism (VTE) Prevention Software Market Size Share by Application (2021-2032) Figure 32. Europe Venous Thromboembolism (VTE) Prevention Software Market Size Share by Application (2021-2032) Figure 33. Asia-Pacific Venous Thromboembolism (VTE) Prevention Software Market Size Share by Application (2021-2032) Figure 34. Latin America Venous Thromboembolism (VTE) Prevention Software Market Size Share by Application (2021-2032) Figure 35. Middle East and Africa Venous Thromboembolism (VTE) Prevention Software Market Size Share by Application (2021-2032) Figure 36. Global Top 5 and 10 Venous Thromboembolism (VTE) Prevention Software Players Market Share by Revenue in 2025 Figure 37. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 38. North America Venous Thromboembolism (VTE) Prevention Software Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 39. North America Venous Thromboembolism (VTE) Prevention Software Market Share by Country: 2021 VS 2025 VS 2032 Figure 40. North America Venous Thromboembolism (VTE) Prevention Software Market Share by Country (2021-2032) Figure 41. Europe Venous Thromboembolism (VTE) Prevention Software Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. Europe Venous Thromboembolism (VTE) Prevention Software Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Venous Thromboembolism (VTE) Prevention Software Market Share by Country (2021-2032) Figure 44. Asia-Pacific Venous Thromboembolism (VTE) Prevention Software Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 45. Asia-Pacific Venous Thromboembolism (VTE) Prevention Software Market Share by Country: 2021 VS 2025 VS 2032 Figure 46. Asia-Pacific Venous Thromboembolism (VTE) Prevention Software Market Share by Country (2021-2032) Figure 47. Latin America Venous Thromboembolism (VTE) Prevention Software Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Latin America Venous Thromboembolism (VTE) Prevention Software Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Latin America Venous Thromboembolism (VTE) Prevention Software Market Share by Country (2021-2032) Figure 50. Middle East & Africa Venous Thromboembolism (VTE) Prevention Software Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 51. Middle East & Africa Venous Thromboembolism (VTE) Prevention Software Market Share by Country: 2021 VS 2025 VS 2032 Figure 52. Middle East & Africa Venous Thromboembolism (VTE) Prevention Software Market Share by Country (2021-2032) Figure 53. Years Considered Figure 54. Research Process Figure 55. Key Executives Interviewed

Scope & coverage.

Types
  • Cloud-based
  • On-premise
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Aidoc
  • Xiangyu Medical
  • Xunfei Healthcare
  • Shanghai SYNYI AI
  • Shanghai Clinbrain
  • SmartCode Technology
  • Zhixuan Internet
  • Biovision Software
  • Lianyungang Xunda Seal Engraving Service
  • Donghua Medical Technology
  • Guangzhou Laino Information Technology

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Venous Thromboembolism (VTE) Prevention Software Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Venous Thromboembolism (VTE) Prevention Software Market Size by Region (2021-2032)
  5. 1.4.1 Global Venous Thromboembolism (VTE) Prevention Software Market Size by Region (2021-2026)
  6. 1.4.2 Global Venous Thromboembolism (VTE) Prevention Software Market Size by Region (2027-2032)
  7. 1.5 Key Regions Venous Thromboembolism (VTE) Prevention Software Market Size (2021-2032)
  8. 1.5.1 North America Venous Thromboembolism (VTE) Prevention Software Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Venous Thromboembolism (VTE) Prevention Software Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Venous Thromboembolism (VTE) Prevention Software Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Venous Thromboembolism (VTE) Prevention Software Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Venous Thromboembolism (VTE) Prevention Software Market Size Growth Rate (2021-2032)
2 Venous Thromboembolism (VTE) Prevention Software Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Cloud-based
  3. 2.1.2 On-premise
  4. 2.2 Global Venous Thromboembolism (VTE) Prevention Software Market Size by Type
  5. 2.2.1 Global Venous Thromboembolism (VTE) Prevention Software Market Size Overview by Type (2021-2032)
  6. 2.2.2 Global Venous Thromboembolism (VTE) Prevention Software Historic Market Size Review by Type (2021-2026)
  7. 2.2.3 Global Venous Thromboembolism (VTE) Prevention Software Market Size Forecasted by Type (2027-2032)
  8. 2.3 Global Venous Thromboembolism (VTE) Prevention Software Market Size by Regions
  9. 2.3.1 North America Venous Thromboembolism (VTE) Prevention Software Market Size Breakdown by Type (2021-2026)
  10. 2.3.2 Europe Venous Thromboembolism (VTE) Prevention Software Market Size Breakdown by Type (2021-2026)
  11. 2.3.3 Asia-Pacific Venous Thromboembolism (VTE) Prevention Software Market Size Breakdown by Type (2021-2026)
  12. 2.3.4 South America Venous Thromboembolism (VTE) Prevention Software Market Size Breakdown by Type (2021-2026)
  13. 2.3.5 Middle East and Africa Venous Thromboembolism (VTE) Prevention Software Market Size Breakdown by Type (2021-2026)
3 Venous Thromboembolism (VTE) Prevention Software Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Hospital
  3. 3.1.2 Clinic
  4. 3.1.3 Other
  5. 3.2 Global Venous Thromboembolism (VTE) Prevention Software Market Size by Application
  6. 3.2.1 Global Venous Thromboembolism (VTE) Prevention Software Market Size Overview by Application (2021-2032)
  7. 3.2.2 Global Venous Thromboembolism (VTE) Prevention Software Historic Market Size Review by Application (2021-2026)
  8. 3.2.3 Global Venous Thromboembolism (VTE) Prevention Software Market Size Forecasted by Application (2027-2032)
  9. 3.3 Global Venous Thromboembolism (VTE) Prevention Software Market Size by Regions
  10. 3.3.1 North America Venous Thromboembolism (VTE) Prevention Software Market Size Breakdown by Application (2021-2026)
  11. 3.3.2 Europe Venous Thromboembolism (VTE) Prevention Software Market Size Breakdown by Application (2021-2026)
  12. 3.3.3 Asia-Pacific Venous Thromboembolism (VTE) Prevention Software Market Size Breakdown by Application (2021-2026)
  13. 3.3.4 South America Venous Thromboembolism (VTE) Prevention Software Market Size Breakdown by Application (2021-2026)
  14. 3.3.5 Middle East and Africa Venous Thromboembolism (VTE) Prevention Software Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Venous Thromboembolism (VTE) Prevention Software Industry Trends
  2. 4.2 Venous Thromboembolism (VTE) Prevention Software Industry Drivers
  3. 4.3 Venous Thromboembolism (VTE) Prevention Software Industry Opportunities and Challenges
  4. 4.4 Venous Thromboembolism (VTE) Prevention Software Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Venous Thromboembolism (VTE) Prevention Software Revenue (2021-2026)
  2. 5.2 Global Venous Thromboembolism (VTE) Prevention Software Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Venous Thromboembolism (VTE) Prevention Software Key Company Headquarters & Area Served
  4. 5.4 Global Venous Thromboembolism (VTE) Prevention Software Company, Product Type & Application
  5. 5.5 Global Venous Thromboembolism (VTE) Prevention Software Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Venous Thromboembolism (VTE) Prevention Software Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Venous Thromboembolism (VTE) Prevention Software Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Venous Thromboembolism (VTE) Prevention Software Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Aidoc
  2. 6.1.1 Aidoc Company Information
  3. 6.1.2 Aidoc Business Overview
  4. 6.1.3 Aidoc Venous Thromboembolism (VTE) Prevention Software Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Aidoc Venous Thromboembolism (VTE) Prevention Software Product Portfolio
  6. 6.1.5 Aidoc Recent Developments
  7. 6.2 Xiangyu Medical
  8. 6.2.1 Xiangyu Medical Company Information
  9. 6.2.2 Xiangyu Medical Business Overview
  10. 6.2.3 Xiangyu Medical Venous Thromboembolism (VTE) Prevention Software Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Xiangyu Medical Venous Thromboembolism (VTE) Prevention Software Product Portfolio
  12. 6.2.5 Xiangyu Medical Recent Developments
  13. 6.3 Xunfei Healthcare
  14. 6.3.1 Xunfei Healthcare Company Information
  15. 6.3.2 Xunfei Healthcare Business Overview
  16. 6.3.3 Xunfei Healthcare Venous Thromboembolism (VTE) Prevention Software Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Xunfei Healthcare Venous Thromboembolism (VTE) Prevention Software Product Portfolio
  18. 6.3.5 Xunfei Healthcare Recent Developments
  19. 6.4 Shanghai SYNYI AI
  20. 6.4.1 Shanghai SYNYI AI Company Information
  21. 6.4.2 Shanghai SYNYI AI Business Overview
  22. 6.4.3 Shanghai SYNYI AI Venous Thromboembolism (VTE) Prevention Software Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Shanghai SYNYI AI Venous Thromboembolism (VTE) Prevention Software Product Portfolio
  24. 6.4.5 Shanghai SYNYI AI Recent Developments
  25. 6.5 Shanghai Clinbrain
  26. 6.5.1 Shanghai Clinbrain Company Information
  27. 6.5.2 Shanghai Clinbrain Business Overview
  28. 6.5.3 Shanghai Clinbrain Venous Thromboembolism (VTE) Prevention Software Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Shanghai Clinbrain Venous Thromboembolism (VTE) Prevention Software Product Portfolio
  30. 6.5.5 Shanghai Clinbrain Recent Developments
  31. 6.6 SmartCode Technology
  32. 6.6.1 SmartCode Technology Company Information
  33. 6.6.2 SmartCode Technology Business Overview
  34. 6.6.3 SmartCode Technology Venous Thromboembolism (VTE) Prevention Software Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 SmartCode Technology Venous Thromboembolism (VTE) Prevention Software Product Portfolio
  36. 6.6.5 SmartCode Technology Recent Developments
  37. 6.7 Zhixuan Internet
  38. 6.7.1 Zhixuan Internet Company Information
  39. 6.7.2 Zhixuan Internet Business Overview
  40. 6.7.3 Zhixuan Internet Venous Thromboembolism (VTE) Prevention Software Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Zhixuan Internet Venous Thromboembolism (VTE) Prevention Software Product Portfolio
  42. 6.7.5 Zhixuan Internet Recent Developments
  43. 6.8 Biovision Software
  44. 6.8.1 Biovision Software Company Information
  45. 6.8.2 Biovision Software Business Overview
  46. 6.8.3 Biovision Software Venous Thromboembolism (VTE) Prevention Software Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Biovision Software Venous Thromboembolism (VTE) Prevention Software Product Portfolio
  48. 6.8.5 Biovision Software Recent Developments
  49. 6.9 Lianyungang Xunda Seal Engraving Service
  50. 6.9.1 Lianyungang Xunda Seal Engraving Service Company Information
  51. 6.9.2 Lianyungang Xunda Seal Engraving Service Business Overview
  52. 6.9.3 Lianyungang Xunda Seal Engraving Service Venous Thromboembolism (VTE) Prevention Software Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Lianyungang Xunda Seal Engraving Service Venous Thromboembolism (VTE) Prevention Software Product Portfolio
  54. 6.9.5 Lianyungang Xunda Seal Engraving Service Recent Developments
  55. 6.10 Donghua Medical Technology
  56. 6.10.1 Donghua Medical Technology Company Information
  57. 6.10.2 Donghua Medical Technology Business Overview
  58. 6.10.3 Donghua Medical Technology Venous Thromboembolism (VTE) Prevention Software Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Donghua Medical Technology Venous Thromboembolism (VTE) Prevention Software Product Portfolio
  60. 6.10.5 Donghua Medical Technology Recent Developments
  61. 6.11 Guangzhou Laino Information Technology
  62. 6.11.1 Guangzhou Laino Information Technology Company Information
  63. 6.11.2 Guangzhou Laino Information Technology Business Overview
  64. 6.11.3 Guangzhou Laino Information Technology Venous Thromboembolism (VTE) Prevention Software Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Guangzhou Laino Information Technology Venous Thromboembolism (VTE) Prevention Software Product Portfolio
  66. 6.11.5 Guangzhou Laino Information Technology Recent Developments
7 North America
  1. 7.1 North America Venous Thromboembolism (VTE) Prevention Software Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Venous Thromboembolism (VTE) Prevention Software Market Size by Country (2021-2026)
  3. 7.3 North America Venous Thromboembolism (VTE) Prevention Software Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Venous Thromboembolism (VTE) Prevention Software Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Venous Thromboembolism (VTE) Prevention Software Market Size by Country (2021-2026)
  3. 8.3 Europe Venous Thromboembolism (VTE) Prevention Software Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Venous Thromboembolism (VTE) Prevention Software Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Venous Thromboembolism (VTE) Prevention Software Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Venous Thromboembolism (VTE) Prevention Software Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Venous Thromboembolism (VTE) Prevention Software Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Venous Thromboembolism (VTE) Prevention Software Market Size by Country (2021-2026)
  3. 10.3 South America Venous Thromboembolism (VTE) Prevention Software Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Venous Thromboembolism (VTE) Prevention Software Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Venous Thromboembolism (VTE) Prevention Software Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Venous Thromboembolism (VTE) Prevention Software Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research